4[1]Biton V.Preliminary open-label experience with topiramate in primary generalized seizures.Epilepsia,1997,38(1):42-48
5[2]Woolf CJ,Mannion RJ.Neuropathic pain:aetiology,Symptoms,mechanism and management.Lancet,1999,353:1959
6[3]Lindberger M,Tomson J,ohman I,et al.Estimation of Topiramate in subdural cerebrospinal fluid,Subcutaneous extracellular fluid,and plasma:a single case microdialysis study.Epilepsia,1999,40:800-802
7[4]Johannessen SI.Pharmacokinetics and interaction profile of topiramate:review and Comparison with other newer antiepileptic drugs.Epilepsia,1997,38(1):18-23
8[5]Reife R,Pledger G,Wu S.Topiramate as addon therapy:Pooled analysis of randomized controlled trials in adults.Epilepsia,2000,41(1):66-71
9[7]Biton V,Montouris GD,Ritter F,et al.A randomized,Placebo-controlled study of topiramate in primary generalized.tonic-clonic seizures.Neurology,1999,52:1330-1337
10[8]Brodie MJ,Biton V,Montouris GD,et al.Topiramate therapy in patients with generalized tonic-clonic seizures without focal onset:long-term outcome.Epilepsia,1998,39(2):2-7
